Director, UC Davis Comprehensive Cancer Center
Welcome to the summer edition of Synthesis magazine. This issue reflects a season of new beginnings, bold ideas and a deepened commitment to the patients and communities we serve.
The spirit of progress begins with new leadership. In this issue of Synthesis, you will meet Mark Rosenblatt, who joined UC Davis Health this year as vice chancellor of human health sciences. This role is something of a homecoming. He began his academic career at UC Davis in 2005 as an assistant professor of ophthalmology and vision science, balancing research in Davis with patient care in Sacramento.
Innovation is a constant thread throughout this issue. One powerful example is the newly established Endowed Professorship of Neurosurgical Research, made possible by a generous $1.5 million anonymous gift. The professorship has been awarded to Laura Marcu, whose work in light-based and biophotonic technologies holds promise for improving cancer care and treating other complex diseases. This support will accelerate scientific discovery and help move new technologies from the lab to the bedside — where they can make a real difference for patients.
The spirit of discovery also shines through in our story that explores how cells constantly mend broken DNA. This major scientific advancement could lead to more effective treatments for cancer and genetic diseases, reminding us that even the smallest processes in our bodies can have enormous implications for health.
Several features in this issue focus on transforming cancer care through precision approaches. Cancer center scientists are testing “smart” nanotechnology designed to deliver cancer drugs directly to tumors while sparing healthy tissue. This work is underway in our Center for Experimental Therapeutics in Cancer and reflects our drive to make treatments more effective and gentler for patients.
We also take a closer look at breast cancer care, an especially important topic as rates continue to rise — particularly among women younger than 50. You’ll learn how we are expanding breast cancer care by helping patients move more quickly and compassionately from diagnostic imaging to treatment.
Colorectal cancer rates are also increasing among adults under 50, and we speak with Dr. Ankit Sarin about the newest strategies for prevention and early detection in younger patients.
Radiology advancements continue. UC Davis Health is now home to the region’s first photon-counting CT scanner, offering clearer images with less radiation. Patients receiving radiation therapy can benefit from another new technology – the Accuray Radixact System – delivering more personalized and precise treatment. Together, these advances underscore our focus on patient-centered care.
Clinical trials remain essential to progress. This issue highlights a new trial for patients with high-risk non-Hodgkin lymphoma, offering hope for those who need better options. One particular patient reminds us why this research matters.
Finally, we share the moving story of Tyson Duncan and the enduring legacy his family created through a new fund to support pediatric oncology patients and families when they need it most.
Thank you for your continued trust, support and giving. It fuels discovery, compassion and hope. Enjoy this summer issue of Synthesis.
